Li Xiaoli

Hu Xumeng, Zhang Beibei, Li Xiaoli, Li Miao, Wang Yange, Dan Handong et al.

CRISPR/Cas9 shows promise for gene therapy across numerous eye diseases like glaucoma, offering therapeutic avenues. However, significant challenges remain for clinical application.

Li Xiaoli, Xie Jie, Zhang Liang, Cui Ying, Zhang Guanrong, Chen Xiangting et al.

OCTA revealed specific microvascular and neural parameters that correlate with diabetic retinopathy severity, offering potential for improved screening and staging.